When it comes to cost, AstraZeneca’s vaccine is also undoubtedly more cost effective in the short-term.
Set to be manufactured in Australia, it comes in at about US$2.50 (AU$3.25) per dose compared to Pfizer at US$20 (AU$26) and Moderna between US$15–25 (AU$19.50–32.20) per dose, with an additional outlay for cold chain infrastructure.
